The viral and non-viral vector manufacturing market is projected to grow at an annualized rate of over 15%, claims Roots Analysis
London
Roots Analysis has announced the addition of “Viral Vectors,
Non-Viral Vectors and Gene Therapy Manufacturing Market
(4th Edition) 2021 – 2030” report to its list of offerings.
Over time, ~15 cell and gene therapies have been
approved across the world. Since transgene delivery into biological producing
cell lines, gene modified cell-based therapies and the body, is an
indispensable aspect of modern drug / therapy development efforts, high quality
vectors are required by both medical researchers, drug developers and
manufact7uring service providers, alike. In order to save time and costs, many
stakeholders in the cell and gene therapy market have opted to outsource their
vector manufacturing needs.
To order this 685+ page report, which features
170+ figures and 290+ tables, please visit https://www.rootsanalysis.com/reports/view_document/viral-vectors-non-viral-vectors-and-gene-therapy-manufacturing-market-/274.html
Key Market Insights
The market features
the presence of over 225 industry players and non-industry players
It is currently
dominated by the presence of mid-sized players (51-500 employees), which
represent more than 55% of industry stakeholders, worldwide. Of these, ~80% are
capable of synthesizing different types of viral vectors, and round 10% of
the companies mentioned in the report claim to have expertise in manufacturing
plasmid DNA.
Over the time,
several new technology platforms have been developed to deal with existing
production-related challenges
Majority (85%) of the
available technologies are currently focused on viral vectors. The technology landscape analysis featured in the report,
highlights the fact that 55% of the contemporary platforms are meant for the
development and production of gene therapies.
Close to 210
partnerships were inked in this market, over the last five years
More than 55% of
partnerships were inked post 2017, with the maximum activity being reported in
2020 (till September). Most of the deals (~27%) were manufacturing
agreements, followed by product / technology licensing (24%), product
development (17%) and R&D (9%) agreements.
To request a sample copy / brochure of
this report, please visit https://www.rootsanalysis.com/reports/274/request-sample.html
About Roots Analysis
Roots Analysis is one of the fastest growing
market research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots
Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Comments
Post a Comment